• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miRNAs 在心力衰竭中的预后价值:一项荟萃分析。

Prognostic value of microRNAs in heart failure: A meta-analysis.

机构信息

Department of Cardiovascular, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, No. 16369, Jingshi Road, Jinan, China.

Department of Vascular Surgery, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.

出版信息

Medicine (Baltimore). 2021 Nov 19;100(46):e27744. doi: 10.1097/MD.0000000000027744.

DOI:10.1097/MD.0000000000027744
PMID:34797300
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8601330/
Abstract

BACKGROUND

Reported studies have shown that expression levels of microRNAs (miRNAs) are related to survival time of patients with heart failure (HF). A systematic review and meta-analysis were conducted to study circulating miRNAs expression and patient outcome.

METHODS

Meta-analysis estimating expression levels of circulating miRNAs in HF patients from January 2010 until June 30, 2018, through conducting online searches in Pub Med, Cochrane Database of Systematic, EMBASE and Web of Science and reviewed by 2 independent researchers. Using pooled hazard ratio with a 95% confidence interval to assess the correlation between miRNAs expression levels and overall survival.

RESULTS

Four relevant articles assessing 19 circulating miRNAs in 867 patients were included. In conclusion, the meta-analysis results suggest that HF patients with low expression of serum miR-1, miR-423-5p, miR-126, miR-21, miR-23, miR-30d, miR-18a-5p, miR-16-5p, miR-18b-5p, miR-27a-3p, miR-26b-5p, miR-30e-5p, miR-106a-5p, miR-233-3P, miR-301a-3p, miR-423-3P, and miR-128 have significantly worse overall survival (P  <  .05). Among them, miR-18a-5p, miR-18b-5p, miR-30d, miR-30e-5p, and miR-423-5p are strong biomarkers of prognosis in HF.

摘要

背景

已有研究表明,微小 RNA(miRNA)的表达水平与心力衰竭(HF)患者的生存时间有关。本系统评价和荟萃分析旨在研究循环 miRNA 表达与患者预后的关系。

方法

通过在 Pub Med、Cochrane 系统评价数据库、EMBASE 和 Web of Science 上在线搜索,对 2010 年 1 月至 2018 年 6 月 30 日发表的 HF 患者循环 miRNA 表达的研究进行荟萃分析,由 2 位独立研究人员进行评估。采用合并危险比(HR)及其 95%置信区间(CI)评估 miRNA 表达水平与总生存率之间的相关性。

结果

纳入了 4 项评估 867 例患者 19 种循环 miRNA 的相关研究。荟萃分析结果表明,血清 miR-1、miR-423-5p、miR-126、miR-21、miR-23、miR-30d、miR-18a-5p、miR-16-5p、miR-18b-5p、miR-27a-3p、miR-26b-5p、miR-30e-5p、miR-106a-5p、miR-233-3P、miR-301a-3p、miR-423-3P 和 miR-128 低表达的 HF 患者总体生存率显著降低(P <.05)。其中,miR-18a-5p、miR-18b-5p、miR-30d、miR-30e-5p 和 miR-423-5p 是 HF 预后的强生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f14d/8601330/b11ab34ea69c/medi-100-e27744-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f14d/8601330/be3311d21905/medi-100-e27744-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f14d/8601330/0c0e7d648827/medi-100-e27744-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f14d/8601330/b11ab34ea69c/medi-100-e27744-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f14d/8601330/be3311d21905/medi-100-e27744-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f14d/8601330/0c0e7d648827/medi-100-e27744-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f14d/8601330/b11ab34ea69c/medi-100-e27744-g003.jpg

相似文献

1
Prognostic value of microRNAs in heart failure: A meta-analysis.miRNAs 在心力衰竭中的预后价值:一项荟萃分析。
Medicine (Baltimore). 2021 Nov 19;100(46):e27744. doi: 10.1097/MD.0000000000027744.
2
Circulating miRNA in functional tricuspid regurgitation. Unveiling novel links to heart failure: A pilot study.功能性三尖瓣反流中的循环 miRNA:揭示与心力衰竭的新关联:一项初步研究。
ESC Heart Fail. 2024 Aug;11(4):2272-2286. doi: 10.1002/ehf2.14765. Epub 2024 Apr 18.
3
MicroRNAs relate to early worsening of renal function in patients with acute heart failure.微小RNA与急性心力衰竭患者肾功能早期恶化有关。
Int J Cardiol. 2016 Jan 15;203:564-9. doi: 10.1016/j.ijcard.2015.10.217. Epub 2015 Nov 11.
4
Identification of novel circulating microRNAs in advanced heart failure by next-generation sequencing.通过下一代测序技术鉴定晚期心力衰竭中的新型循环 microRNAs。
ESC Heart Fail. 2021 Aug;8(4):2907-2919. doi: 10.1002/ehf2.13371. Epub 2021 May 2.
5
Signature of circulating microRNAs in patients with acute heart failure.循环 microRNAs 在急性心力衰竭患者中的特征。
Eur J Heart Fail. 2016 Apr;18(4):414-23. doi: 10.1002/ejhf.332. Epub 2015 Sep 8.
6
Exosomal microRNAs miR-30d-5p and miR-126a-5p Are Associated with Heart Failure with Preserved Ejection Fraction in STZ-Induced Type 1 Diabetic Rats.外泌体 microRNAs miR-30d-5p 和 miR-126a-5p 与 STZ 诱导的 1 型糖尿病大鼠心力衰竭伴射血分数保留相关。
Int J Mol Sci. 2022 Jul 6;23(14):7514. doi: 10.3390/ijms23147514.
7
Diagnostic performance of microRNAs in the detection of heart failure with reduced or preserved ejection fraction: a systematic review and meta-analysis.microRNAs 在检测射血分数降低或保留的心力衰竭中的诊断性能:系统评价和荟萃分析。
Eur J Heart Fail. 2022 Dec;24(12):2212-2225. doi: 10.1002/ejhf.2700. Epub 2022 Oct 27.
8
Analysis of circulating microRNAs in patients with repaired Tetralogy of Fallot with and without heart failure.法洛四联症修复术后伴或不伴心力衰竭患者循环微小RNA的分析
J Transl Med. 2017 Jul 10;15(1):156. doi: 10.1186/s12967-017-1255-z.
9
Rodent heart failure models do not reflect the human circulating microRNA signature in heart failure.啮齿动物心力衰竭模型不能反映人类心力衰竭时循环中的微小RNA特征。
PLoS One. 2017 May 5;12(5):e0177242. doi: 10.1371/journal.pone.0177242. eCollection 2017.
10
Serially measured circulating microRNAs and adverse clinical outcomes in patients with acute heart failure.连续检测循环 microRNAs 与急性心力衰竭患者不良临床结局的关系。
Eur J Heart Fail. 2018 Jan;20(1):89-96. doi: 10.1002/ejhf.950. Epub 2017 Sep 25.

引用本文的文献

1
Circulating miRNAs Signature as a Predictor of Cachexia in Chronic Heart Failure: Diagnostic and Prognostic Implications.循环微小RNA特征作为慢性心力衰竭恶病质的预测指标:诊断和预后意义
J Cardiovasc Transl Res. 2025 Jul 10. doi: 10.1007/s12265-025-10658-3.
2
Plasma miRNAs Correlate with Structural Brain and Cardiac Damage in Friedreich's Ataxia.血浆微小RNA与弗里德赖希共济失调患者的脑结构和心脏损伤相关。
Cerebellum. 2024 Dec 17;24(1):15. doi: 10.1007/s12311-024-01766-y.
3
Diagnostic and prognostic value of microRNA423-5p in patients with heart failure.

本文引用的文献

1
Therapeutic Value of miRNAs in Coronary Artery Disease.miRNAs 在冠状动脉疾病中的治疗价值。
Oxid Med Cell Longev. 2021 Apr 12;2021:8853748. doi: 10.1155/2021/8853748. eCollection 2021.
2
Integrated Analysis of Hub Genes and miRNAs in Dilated Cardiomyopathy.扩张型心肌病中枢纽基因和 microRNA 的综合分析。
Biomed Res Int. 2020 Sep 15;2020:8925420. doi: 10.1155/2020/8925420. eCollection 2020.
3
Chemogenetic activation of intracardiac cholinergic neurons improves cardiac function in pressure overload-induced heart failure.
微小RNA423-5p在心力衰竭患者中的诊断和预后价值
J Cardiothorac Surg. 2024 Oct 1;19(1):550. doi: 10.1186/s13019-024-03091-1.
4
Research Advances in Targeted Therapy for Heart Failure.心力衰竭靶向治疗的研究进展
Rev Cardiovasc Med. 2023 Oct 7;24(10):276. doi: 10.31083/j.rcm2410276. eCollection 2023 Oct.
5
Diagnostic and prognostic value of plasma miR-106a-5p levels in patients with acute heart failure.血浆miR-106a-5p水平在急性心力衰竭患者中的诊断和预后价值。
J Cardiothorac Surg. 2024 Apr 23;19(1):261. doi: 10.1186/s13019-024-02750-7.
6
Profile of serum microRNAs in heart failure with reduced and preserved ejection fraction: Correlation with myocardial remodeling.射血分数降低和保留的心力衰竭患者血清微小RNA谱:与心肌重塑的相关性
Heliyon. 2024 Mar 7;10(6):e27206. doi: 10.1016/j.heliyon.2024.e27206. eCollection 2024 Mar 30.
7
Novel Biomarkers in Early Detection of Heart Failure: A Narrative Review.心力衰竭早期检测中的新型生物标志物:一篇叙述性综述。
Cureus. 2024 Feb 2;16(2):e53445. doi: 10.7759/cureus.53445. eCollection 2024 Feb.
8
Clinical Significance of MicroRNAs, Long Non-Coding RNAs, and CircRNAs in Cardiovascular Diseases.microRNAs、长链非编码 RNAs 和环状 RNAs 在心血管疾病中的临床意义。
Cells. 2023 Jun 14;12(12):1629. doi: 10.3390/cells12121629.
9
Dysregulation of Serum MicroRNA after Intracerebral Hemorrhage in Aged Mice.老年小鼠脑出血后血清微小RNA的失调
Biomedicines. 2023 Mar 8;11(3):822. doi: 10.3390/biomedicines11030822.
10
Expression profiling analysis reveals key microRNA-mRNA interactions in patients with transposition of the great arteries and systemic left and right ventricles.表达谱分析揭示了大动脉转位合并体循环左右心室患者中关键的微小RNA-信使核糖核酸相互作用。
Front Cardiovasc Med. 2023 Jan 12;9:1056427. doi: 10.3389/fcvm.2022.1056427. eCollection 2022.
基因编码刺激心脏内胆碱能神经元可改善压力超负荷诱导的心力衰竭心脏功能。
Am J Physiol Heart Circ Physiol. 2020 Jul 1;319(1):H3-H12. doi: 10.1152/ajpheart.00150.2020. Epub 2020 May 15.
4
Epigenetic Biomarkers in Cardiovascular Diseases.心血管疾病中的表观遗传生物标志物
Front Genet. 2019 Oct 9;10:950. doi: 10.3389/fgene.2019.00950. eCollection 2019.
5
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies.氧化应激和炎症在心力衰竭的发生发展中的作用:从病理生理学到治疗策略。
Eur J Prev Cardiol. 2020 Mar;27(5):494-510. doi: 10.1177/2047487319870344. Epub 2019 Aug 14.
6
MicroRNAs in Cardiac Diseases.心肌疾病中的 microRNAs
Cells. 2019 Jul 18;8(7):737. doi: 10.3390/cells8070737.
7
Anticoagulation therapy in heart failure and sinus rhythm: a systematic review and meta-analysis.心力衰竭伴窦性节律患者的抗凝治疗:系统评价和荟萃分析。
Heart. 2019 Sep;105(17):1325-1334. doi: 10.1136/heartjnl-2018-314381. Epub 2019 Apr 8.
8
Inflammation and fibrosis in murine models of heart failure.心力衰竭小鼠模型中的炎症和纤维化。
Basic Res Cardiol. 2019 Mar 18;114(3):19. doi: 10.1007/s00395-019-0722-5.
9
Association of circulating microRNA-122 with presence and severity of atherosclerotic lesions.循环微小RNA-122与动脉粥样硬化病变的存在及严重程度的关联
PeerJ. 2018 Jul 4;6:e5218. doi: 10.7717/peerj.5218. eCollection 2018.
10
Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: an overview.射血分数保留的心力衰竭中的生物标志物、心肌纤维化和合并症:综述
Arch Med Sci. 2018 Jun;14(4):890-909. doi: 10.5114/aoms.2018.76279. Epub 2018 Jun 11.